Financial cost analysis of a strategy to improve the quality of administrative vaccination data in Uganda-Reference-Cited by-同舟云学术

Financial cost analysis of a strategy to improve the quality of administrative vaccination data in Uganda

Published:2020-01 Issue:5 Volume:38 Page:1105-1113
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Ward Kirsten^ORCID,Mugenyi Kevin,MacNeil Adam,Luzze Henry,Kyozira Carol,Kisakye Annet,Matseketse David,Newall Anthony T.^ORCID,Heywood Anita E.^ORCID,Bloland Peter,Pallas Sarah W.

Funder

Centers for Disease Control and Prevention

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference66 articles.

1. World Health Organization. Immunization, Vaccines and Biologicals. National programmes and systems. Available from: https://www.who.int/immunization/programmes_systems/en/ [accessed: 31 October 2019].

2. Expanded programme on immunization;Keja;World Health Stat Q,1988

3. World Health Organization. Immunization coverage. Available from: https://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/ [accessed: 20 December 2018].

4. Global routine vaccination coverage, 2016;Feldstein;MMWR Morb Mortal Wkly Rep,2017

5. The global vaccine action plan: annex 6: the monitoring and evaluation/accountability framework;World Health Organization,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality improvement interventions targeting immunization data from urban lower-level private-for-profit health service providers in Kampala Capital City: processes and implementation experiences;Discover Health Systems;2024-06-26

2. Administrative Punishment Supervision System Based on Internet of Things Driven by Big Data;Mobile Information Systems;2022-05-09

3. Role of immunobiotic lactic acid bacteria as vaccine adjuvants;Probiotics in the Prevention and Management of Human Diseases;2022

4. Costs modest for vaccination data improvement strategy;PharmacoEconomics & Outcomes News;2019-12